Arcturus Therapeutics
(NASDAQ) ARCT
Arcturus Therapeutics Financials at a Glance
Market Cap
$193.85M
Revenue (TTM)
$45.35M
Net Income (TTM)
-$78.67M
EPS (TTM)
-$2.82
P/E Ratio
-2.42
Dividend
$0.00
Beta (Volatility)
2.01 (High)
Dividend
$0.00
Beta (Volatility)
2.01 (High)
Price
$6.89
Volume
27,363
Open
$6.85
Price
$6.89
Volume
27,363
Open
$6.85
Previous Close
$6.89
Daily Range
$6.83 - $7.17
52-Week Range
$5.85 - $24.17
Estimated Earnings Date
Aug 10, 2026
Dividend
$0.00
Beta (Volatility)
2.01 (High)
Price
$6.89
Volume
27,363
Open
$6.85
Previous Close
$6.89
Daily Range
$6.83 - $7.17
52-Week Range
$5.85 - $24.17
Estimated Earnings Date
Aug 10, 2026
ARCT News
ARCT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Arcturus Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
111
CEO
Joseph E. Payne
Website
www.arcturusrx.comHeadquarters
San Diego, CA 92121, US
ARCT Financials
Key Financial Metrics (TTM)
Gross Margin
91.18%
Operating Margin
-196.72%
Net Income Margin
-173.47%
Return on Equity
-36.55%
Return on Capital
-31.36%
Return on Assets
-32.06%
Earnings Yield
-41.32%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$193.85M
Shares Outstanding
28.42M
Volume
27.36K
Avg. Volume
422.83K
Financials (TTM)
Gross Profit
$41.35M
Operating Income
-$89.22M
EBITDA
-$67.53M
Operating Cash Flow
-$58.57M
Capital Expenditure
-$318.66K
Free Cash Flow
-$58.89M
Cash & ST Invst.
$211.38M
Total Debt
$23.99M
Arcturus Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$610.00K
-97.9%
Gross Profit
-$48.00K
-100.2%
Gross Margin
-7.87%
N/A
Market Cap
$193.85M
N/A
Market Cap/Employee
$1.11M
N/A
Employees
174
N/A
Net Income
-$26.96M
-91.6%
EBITDA
-$26.31M
-98.2%
Quarterly Fundamentals
Total Cash
$211.38M
-2.6%
Total Debt
$23.99M
-43.8%
Accounts Receivable
$1.34M
-90.8%
Inventory
$0.00
N/A
Long Term Debt
$19.68M
-49.5%
Short Term Debt
$4.31M
+17.3%
Return on Assets
-32.06%
N/A
Return on Invested Capital
-42.27%
N/A
Free Cash Flow
-$19.44M
+44.9%
Operating Cash Flow
-$19.44M
+44.7%